about
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursorsProphylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursorsPopulation-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysisPostlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccinePrevalence of HPV infection among females in the United StatesQuadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)HPV genotypes in high grade cervical lesions and invasive cervical carcinoma as detected by two commercial DNA assays, North Carolina, 2001-2006Uptake of 2009 H1N1 vaccine among adolescent females.Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levelsIndications for therapy and treatment recommendations for bacterial vaginosis in nonpregnant and pregnant women: a synthesis of data.Measuring Adolescent Human Papillomavirus Vaccine Coverage: A Match of Sexually Transmitted Disease Clinic and Immunization Registry Data.Prevalence of syphilis seroreactivity in the United States: data from the National Health and Nutrition Examination Surveys (NHANES) 2001-2004.Quadrivalent HPV vaccine safety review and safety monitoring plans for nine-valent HPV vaccine in the United StatesMultiple-type human papillomavirus infection in male anogenital sites: prevalence and associated factorsComprehensive control of human papillomavirus infections and related diseasesNucleic acid amplification tests for diagnosis of Neisseria gonorrhoeae and Chlamydia trachomatis rectal infections.The connection between human papillomavirus and oropharyngeal squamous cell carcinomas in the United States: implications for dentistry.Prevalence of circumcision and herpes simplex virus type 2 infection in men in the United States: the National Health and Nutrition Examination Survey (NHANES), 1999-2004.Prevalence of cervical and oral human papillomavirus infections among US womenAcceptability of Carraguard vaginal microbicide gel among HIV-infected women in Chiang Rai, ThailandMolecular subtyping of Treponema pallidum from North and South Carolina.Cervical specimen order and performance measures of Chlamydia trachomatis diagnostic testing.Updates on human papillomavirus and genital warts and counseling messages from the 2010 Sexually Transmitted Diseases Treatment Guidelines.Trends in pelvic inflammatory disease hospital discharges and ambulatory visits, United States, 1985-2001.Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area.Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States.Prevalence of HPV infection among men: A systematic review of the literature.Seroprevalence of herpes simplex virus types 1 and 2 in pregnant women in the United States.The optimal anatomic sites for sampling heterosexual men for human papillomavirus (HPV) detection: the HPV detection in men studyGenital warts among 18- to 59-year-olds in the United States, national health and nutrition examination survey, 1999--2004.Human papilloma virions in the laboratory.Comparison of methods for detection of Chlamydia trachomatis and Neisseria gonorrhoeae using commercially available nucleic acid amplification tests and a liquid pap smear medium.Evaluation of the Determine Rapid Syphilis TP assay using sera.Developments in the screening for Chlamydia trachomatis: a review.Acceptability of school requirements for human papillomavirus vaccineMonitoring Effect of Human Papillomavirus Vaccines in US Population, Emerging Infections Program, 2008-2012.Uptake of human papillomavirus vaccine among adolescent males and females: Immunization Information System sentinel sites, 2009-2012.Investigation of metronidazole use during pregnancy and adverse birth outcomes.Is vaccine type seropositivity a marker for human papillomavirus vaccination? National Health and Nutrition Examination Survey, 2003-2010.HPV vaccine coverage among men who have sex with men - National HIV Behavioral Surveillance System, United States, 2011
P50
Q24202048-A03CFEEC-3AD3-4294-B85E-9077FDDC1A3BQ24235373-277B73D1-4671-49F6-9E73-8C333767D3C7Q28084924-87A914EF-DD68-4EAB-87E5-A000C23727E1Q28255537-59C9CF96-21D5-40D3-A8DC-727003A32737Q28290509-E73557D7-5386-4329-B7E4-D7154C27C6CAQ28294460-05CDE461-626A-477F-BFA9-D7E43B3F5CE0Q28730863-190FDAED-B1AE-48AE-A748-13509038F1DEQ30399506-7442B954-6E54-4DA2-A34D-DC5C0ACF7579Q30534669-CFF18127-C9E6-44B7-B37E-0F40222EE892Q30734350-DE217DB0-FF2E-4F0A-9FB6-7F6BD635DC5CQ31133268-72EB3985-2E9A-4186-ABFB-E23BBE43628BQ31150255-7531919E-B546-4D1D-B3E3-3E579FA29466Q33166996-633D3045-34B6-430A-815A-E0C986AB23BEQ33633353-52F4DE80-4BD8-4285-A41A-B6F9217950D9Q33772648-081FC285-9902-447A-95EC-711E1FD2D9EFQ33827024-ECB08A89-6B65-4DDF-AE43-600F70F166A5Q33976365-2BF3151C-C8F0-4197-8455-82F9738C1B3AQ34003387-4D9DC5CF-CEB6-4AE0-9EB7-660F5BDDAC91Q34007201-86CA8D59-E4EB-4D62-B090-9D99F1AB9637Q34018830-1DEB1040-3A39-4852-A7CA-2BA67AE90A1AQ34041487-027DD7A6-74B3-431A-B043-70C6294BE76FQ34073427-FEDCBD97-E387-44FF-A126-2A286CF744A7Q34073557-6BECA899-7DCE-4BCF-97FA-A3B9F41E3031Q34471101-D8582230-32A2-40CE-9F07-BEE38A87A364Q34512122-B63AD5EE-0787-4372-AE61-239086C22511Q34559709-BE024F8D-20C7-4F26-A1A1-1539AB5B3B2DQ34567930-485CF432-05DD-4E26-89FC-3DCB0DDB148EQ34604669-375C49F7-0BA8-4E2A-B46F-BE82F5CBE506Q34705454-F4EDB7D5-7741-4247-8D5D-98B51233370DQ34764180-73DDCF05-A3A5-4110-9733-76877C400AE2Q34777995-10DD3C48-9CCA-4319-8A91-F94B271F6720Q34974306-1380EF40-54C9-4411-9D44-13DA5387C9DFQ35541981-F6B6F76A-B096-4229-88F4-A872E22A49E8Q35627542-8DFE49CA-51AA-4AF7-BCFF-E2A87EAD7435Q35987591-A4B103A7-BC56-4BAD-9B3A-98FDC1AB9591Q35997434-628AE290-8D37-4790-8121-55DD579E760AQ36121464-285FABB5-1B7C-48E2-82A0-FF8CC3ECB2D3Q36172432-D89E2E7C-CFBA-4513-BB59-15597899EE77Q36318591-0FD30C1A-B7D4-4FA6-9251-E512AA775E82Q36368353-E8DBAE11-8062-4431-AE1E-5F3965B7BF27
P50
name
Lauri E Markowitz
@en
Lauri E Markowitz
@nl
type
label
Lauri E Markowitz
@en
Lauri E Markowitz
@nl
prefLabel
Lauri E Markowitz
@en
Lauri E Markowitz
@nl